Durect Corp (DRRX)

개요 뉴스 가격 이력 옵션 체인 Financials DRRX 왜 하락? 토론 예측 주식 분할

Relative Volume:

Durect Corp Stock (DRRX) Company Profile

Healthcare (1164)

(408) 777-1417

10240 BUBB ROAD, CUPERTINO, CA

최신 SEC 제출 서류

DRRX's Discussions on Twitter

DRRX을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
DRRX Durect Corp	1.895	58.05M	8.59M	-17.07M	-21.90M	-0.61
ZTS Zoetis Inc	152.03	66.04B	9.39B	2.61B	2.22B	5.81
TAK Takeda Pharmaceutical Co Adr	14.75	45.57B	29.98B	958.27M	5.31B	0.2964
HLN Haleon Plc Adr	9.695	42.50B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	17.17	18.84B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	307.85	13.59B	2.99B	1.21B	1.13B	25.06

Durect Corp Stock (DRRX) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2020-10-30	개시	Chardan Capital Markets	Buy
2020-10-12	개시	ROTH Capital	Buy
2020-07-31	개시	Oppenheimer	Outperform
2020-01-31	개시	B. Riley FBR	Buy
2019-11-18	재개	Cantor Fitzgerald	Overweight
2019-09-06	개시	Cantor Fitzgerald	Overweight
2018-03-06	업그레이드	H.C. Wainwright	Neutral → Buy
2017-10-20	다운그레이드	H.C. Wainwright	Buy → Neutral
2017-10-20	재확인	Laidlaw	Buy
2017-10-20	다운그레이드	Stifel	Buy → Hold
2017-07-12	업그레이드	Stifel	Hold → Buy
2017-02-28	재개	H.C. Wainwright	Buy
2016-04-25	개시	Rodman & Renshaw	Buy
2015-05-01	재확인	Cantor Fitzgerald	Buy
2015-05-01	재확인	Stifel	Buy
2013-03-25	개시	Stifel	Buy
2012-11-01	다운그레이드	C.K. Cooper	Buy → Hold
2012-08-17	개시	C.K. Cooper	Buy
2009-06-23	개시	Caris & Company	Buy
2009-03-26	개시	Wedbush Morgan	Hold

Durect Corp 주식(DRRX)의 최신 뉴스

Durect Corp (DRRX) 재무 분석

Durect Corp (DRRX)

Durect Corp Stock (DRRX) Company Profile

DRRX을(를) 다른 주식과 비교

Durect Corp Stock (DRRX) Upgrades & Downgrades

Durect Corp 주식(DRRX)의 최신 뉴스

DURECT Corporation Reversal Rally May Surprise BearsQuarterly Market Summary & Short-Term Trading Opportunity Alerts - 선데이타임즈

Will DURECT Corporation continue its uptrendQuarterly Market Review & Verified Entry Point Signals - Newser

Sentiment analysis tools applied to DURECT Corporation2025 Volatility Report & Growth-Oriented Investment Plans - Newser

Durect: Q2 Earnings Snapshot - Connecticut Post

Can swing trading help recover from DURECT Corporation losses [Portfolio Profit Report]Weekly Top Gainers Trade List - Newser

Published on: 2025-08-12 20:28:09 - Newser

Using economic indicators to assess DURECT Corporation potentialJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - Newser

Durect (DRRX) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

DURECT (DRRX) Reports Q2 2025 Results, Press Release Attached | DRRX SEC FilingForm 8-K - Stock Titan

Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan

Market reaction to DURECT Corporation’s recent newsMomentum-Based Prediction for Quick Returns - Newser

Why DURECT Corporation stock attracts strong analyst attentionPredictive Analytics for Equity Growth Potential - Newser

Technical signs of recovery in DURECT CorporationTechnical Insight Guide for Safer Trades - Newser

Is DURECT Corporation reversing from oversold territoryFree Daily Top Performing Stock Insights - Newser

Using data tools to time your DURECT Corporation exitEquity Performance Forecast Based on AI Models - Newser

Reversal indicators forming on DURECT Corporation stockPortfolio Update Report & Expert Curated Trade Ideas - Newser

DURECT (DRRX) Projected to Post Quarterly Earnings on Tuesday - Defense World

Signal strength of DURECT Corporation stock in tech scannersReal-Time Entry Forecast with Accuracy Metrics - Newser

Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - Insider Monkey

Durect Extends Tender Offer Deadline in Merger with Bausch Health. - AInvest

Using R and stats models for DURECT Corporation forecastingAlpha Generation Strategy with Low Volatility - Newser

Visualizing DURECT Corporation stock with heatmapsDay Trading Plan with Entry Risk Management - Newser

What is DURECT Corporation company’s growth strategyFree Investment Community - Jammu Links News

Can volume confirm reversal in DURECT CorporationSmart Forecast Signals from AI Models - Newser

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NSC, SNV, DRRX, PNFP on Behalf of Shareholders - Eastern Progress

What makes DURECT Corporation stock price move sharplyRisk/Reward Optimization Entry Point Analysis - Newser

Does DURECT Corporation show high probability of reboundMarket Correction Proof Stock Screening Analysis - Newser

Bausch Health files SC TO-C ahead of tender offer for DURECT (DRRX) | DRRX SEC FilingForm SC TO-C - Stock Titan

Bausch Health expands liver disease portfolio with DURECT Corp buy - The Pharma Letter

Can swing trading help recover from DURECT Corporation lossesSwing Watchlist With Tight Stop Placement - Newser

What does recent volatility data suggest for DURECT CorporationLow Risk High Confidence Watchlist Builder - Newser

Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN

Durect Corp: Analyzing DRRX Stock Trends - investchronicle.com

Specificity Inc. (OTCID: SPTY) AI-Powered Technology Poised to Disrupt the Media Sector – More Stocks Inside - FinancialContent

Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout - inkl

Crude Oil Gains Over 1%; UnitedHealth Earnings Miss Views - Benzinga

Bausch Health to buy Durect for $63M upfront; Fulcrum’s Ph1b sickle cell data - Endpoints News

US Stocks Mixed; Procter & Gamble Posts Upbeat Earnings - Benzinga

Bausch Health stock rises, Durect flies after acquisition deal By Investing.com - Investing.com Canada

Bausch Health stock rises, Durect flies after acquisition deal - Investing.com

DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders - Business Wire

Durect stock rises on M&A deal with Bausch Health (BHC:NYSE) - Seeking Alpha

DRRX to be acquired by Bausch for $1.75 cash + CVR worth up to $350M | DRRX SEC FilingForm 8-K - Stock Titan

Bausch Health To Acquire DURECT; Expanding Liver Disease Pipeline With Larsucosterol - Nasdaq

Bausch Health to acquire DURECT in $63 million deal for liver disease drug - Investing.com Canada

Bausch Health to acquire DURECT for $63 million upfront By Investing.com - Investing.com Canada

Bausch Health to launch tender offer for DURECT; Schedule TO-C filed | DRRX SEC FilingForm SC TO-C - Stock Titan

Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - PR Newswire

When is the best time to exit AA Mission Acquisition Corp.Free Community Shared Smart Money Signals - Newser

Is ICF International Inc. stock overhyped or has real potentialFree Low Risk Buy Zone Opportunity Watch - Newser

How Aeries Technology Inc Equity Warrant stock performs during market volatilityFree Accurate Technical Trend Reversal Picks - Newser

Durect Corp (DRRX) 재무 분석

매출

순이익

현금흐름

주당 순 이익

DRRX과 유사한 종목